3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
11
Phase 1
5
Phase NA
4
Phase 3
2
Phase 1/2
2
Phase EARLY_PHASE1
1
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
3
Carcinoma, Hepatocellular
2
Breast Neoplasms
2
Stomach Neoplasms
1
Pancreatic Adenocarcinoma
1
Pain
1
Neoplasm Metastasis
1
NSCLC
1
Lymphatic Metastasis
1
Colorectal Neoplasms
1
Castration-resistant Prostate Cancer Patients with Oligometastases
1
Carcinoma, Non-Small-Cell Lung
1
Adenocarcinoma
1
Interventions
Oxaliplatin
15
Fluorouracil
13
Bevacizumab
13
Leucovorin
10
Capecitabine
8
Folfox protocol
7
Irinotecan
6
IFL protocol
4
Cetuximab
4
Folic Acid
3
Aspirin
3
atezolizumab
2
XELOX
2
Surgical Procedures, Operative
2
Magnetic Resonance Spectroscopy
2
Drug Therapy
2
Chemotherapy, Adjuvant
2
trifluridine tipiracil drug combination
1
trametinib
1
titanium silicide
1
sulindac sulfone
1
spartalizumab
1
sacituzumab govitecan
1
regorafenib
1
raltitrexed
1
pertuzumab
1
irinotecan sucrosofate
1
folfirinox
1
envafolimab
1
dabrafenib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2/3
×
Colorectal Neoplasms
×
Radiosurgery
×
Clear all
NCT06185556
2024-08-23
COLDFIRE-III
Amsterdam UMC, location VUmc
Phase 2/3
Recruiting
78 enrolled